http://www.fpnotebook.com/
Onychomycosis
Aka: Onychomycosis, Tinea Unguium- Definition
- Fungal infection affecting the Toenail or Fingernail
- Epidemiology
- Prevalence: 10% of population affected worldwide
- Most common Nail Disorder (accounts for 50% of Nail Disorders)
- Rarely occurs in children unless predisposing factors
- Immunosuppression (e.g. AIDS)
- Extensive fungal skin involvement
- Family History of Onychomycosis
- Pathophysiology
- Person to person transmission
- Risk Factors
- Older age (especially over age 60 years)
- Tinea Pedis
- Swimming
- Psoriasis
- Immunodeficiency
- Types
- Distal Subungual (most common)
- Affects distal and lateral Toenails and Fingernails
- Associated with Tinea Pedis
- Most common etiology: Trichophyton rubrum
- White superficial Onychomycosis (10% of cases)
- Most common etiology: Trichophyton mentagrophytes
- May affect entire Toenails
- Starts as opaque, well demarcated white spots
- Spots coalesce to involve entire nail
- Proximal Subungual (least common)
- Most common etiology: Trichophyton rubrum
- Affects proximal Fingernails and Toenails
- Fungi invade proximal nail fold to enter nail
- Predisposing factors
- Immunocompromised status (e.g. AIDS)
- Local trauma
- Candida Onychomycosis (rare)
- Associated with Chronic Paronychia (Candida)
- More common in immunocompromised state
- Total dystrophic Onychomycosis
- Total nail plate destruction from above types
- Distal Subungual (most common)
- Signs: Nail plate changes
- Discoloration (white or yellow)
- Opacification
- Distribution based on type (see above)
- Labs
- Potassium Hydroxide (KOH): Subungual debris scraping
- Test Sensitivity: 80%
- Test Specificity: 72%
- Nail Biopsy: Periodic acid schiff stain (effective, but expensive and not widely available)
- Test Sensitivity: 92%
- Test Specificity: 72%
- Fungal Culture
- Efficacy
- Test Sensitivity: 59%
- Test Specificity: 82%
- Distal subungual Onychomycosis
- Clip nail short
- Apply curette to nail bed near cuticle for sample
- Also scrape underside of nail plate
- White superficial Onychomycosis
- Scrape nail plate surface white area for sample
- Proximal superficial Onychomycosis
- Pare nail plate near lunula
- Curette sample from infected nail bed
- Candidal Onychomycosis
- Efficacy
- Potassium Hydroxide (KOH): Subungual debris scraping
- Differential Diagnosis
- Only 50% of Dystrophic Nails are Onychomycosis
- Candida Paronychia (Chronic Paronychia)
- Bacterial Paronychia (Acute Paronychia)
- Herpetic Whitlow (Herpes Simplex Virus)
- Psoriasis
- Lichen Planus
- Contact Dermatitis
- Local nail trauma
- Nail bed tumor
- Yellow Nail Syndrome
- Management: General Measures
- Keep feet dry
- Wear cotton socks and change 2-3 times per day
- Wear shoes that are breathable
- Reduce fungus exposure
- Wear foot protection in shared showers (locker room)
- Treat Tinea Pedis
- Consider nail removal in severe Onycholysis
- Optimize chronic disease management
- Antifungal Medications
- Consider Topical Antifungal as adjunct to those below
- Consider longer Antifungal course in some patients
- Slow Nail Growth
- Extensive nail plate involvement
- Diminished blood supply
- Keep feet dry
- Management: Antifungal agents
- Terbinafine (Lamisil)
- See Terbinafine for dosing and monitoring
- Most effective oral Antifungal agent for treatment of Onychomycosis
- Cure rate: 79-84%
- Dose used: 250 mg daily for 3 months
- Evans (1999) BMJ 318:1031-5
- Faergernann (1995) J Am Acad Dermatol 32: 750-3
- Itraconazole (Sporanox)
- See Itraconazole for dosing and monitoring
- Cure rate: 64-72%
- Dose used: 400 mg/dose intermittently for 3-4 months (72% cure rate was for the 4 months of treatment)
- De Doncker (1996) Arch Dermatol 132:34-41
- Fluconazole (Diflucan)
- See Fluconazole for dosing and monitoring
- Cure rate: 62%
- Dose used: 450 mg weekly for up to 12 months
- Scher (1998) J Am Acad Dermatol 38:S77-S86
- Terbinafine (Lamisil)
- Management: Ineffective agents (avoid these)
- Griseofulvin
- Low cure rates (30-45%) even when taken for up to 6-12 months at 500-1000 mg daily
- Faergernann (1995) J Am Acad Dermatol 32: 750-3
- Ciclopirox (Penlac)
- Topical agents are not effective in Onychomycosis
- Requires 48 week application
- Marginally better than Placebo
- Griseofulvin
- Prognosis
- Recurrence rate: 20-50%
- References
- Gilbert (1999) Sanford Guide to Antimicrobials
- Andrews (2008) Am Fam Physician 77(10): 1415-20
- Crawford (2002) Arch Dermatol 138: 811-6
- Crissey (1998) Postgrad Med 103(2):191-205
- Gupta (1997) Dermatol Clin 15(1):121-35
- Harrell (2000) J Am Board Fam Pract 13:268-73
- Rodgers (2001) Am Fam Physician 63(4):663-72
- Scher (1999) J Am Acad Dermatol 40:S21-6
- Weinberg (2003) J Am Acad Dermatol 49:193-7